EU Clears Kimberly-Clark Kenvue Deal
The European Commission approved Kimberly-Clark's acquisition of Kenvue after the company agreed to sell its European feminine hygiene brands. Dilek Gida Uretim will acquire the divested assets, addressing antitrust concerns.
Xurve View
Insights:
Xurve View
KIMBERLY-CLARK CORP secured European Commission approval on Monday afternoon for its $40B acquisition of KENVUE INC after offering structural remedies. The clearance removes the primary regulatory hurdle for the consumer-goods megamerger. The deal pairs Kimberly-Clark's diaper and tissue brands with Kenvue's over-the-counter health portfolio, which includes Tylenol.
